Pharmaceuticals
* Please select month and year together
Africure Pharmaceuticals Ltd: Advancing healthcare in Africa through the manufacturing, distribution, and trading of essential pharmaceuticals.
Pharmaceuticals | Mauritius
Africure Pharmaceuticals Ltd financial results for the year ending 31 March 2025. Revenue from operations increased 10% year-on-year to $29.77 million. EBITDA grew 14% to $3.73 million, with an EBITDA margin of 13%. Net Loss After Tax was $2.81 million, which includes losses from discontinued operations in Nigeria, Mali, and […]
Document type: Annual Reports
Published: Nov 19, 2025
Year: 2025
Period:
Pharmaceuticals | Mauritius
Africure Pharmaceuticals Ltd has released its interim financial results for the six months ended 30 September 2025. Revenue for the period was USD 11.59 million, a 30% decrease year-on-year. The company recorded a net loss of USD 528,480, resulting in earnings per share of (USD 0.06). This compares to a […]
Document type: Interim Reports
Published: Nov 17, 2025
Year: 2026
Period: HY
Pharmaceuticals | Mauritius
Dannex Ayrton Starwin Plc, a leading Ghanaian pharmaceutical firm, excels in manufacturing and distributing diverse healthcare products.
Pharmaceuticals | Ghana
Nov 7, 2025 –
Quality Chemical Industries Limited has declared a dividend. The following are the details related to the dividend: Declaration date 31/10/2025 Record date 25/11/2025 Ex-dividend date 21/11/2025 Payment date 05/12/2025 Dividend amount per share 4.2 UGX
Corporate announcement, Dividends | Uganda
Dannex Ayrton Starwin PLC reports financial results for the nine months ended 30 September 2025. Key metrics year-to-date: Revenue: GHC 134.76M, a 3.0% increase. Profit After Tax: GHC 0.51M, a decrease from GHC 6.79M. EPS: GHC 0.0060, down from GHC 0.0802. Total Assets: GHC 116.54M, a 14.8% increase. Total Equity: […]
Document type: Interim Reports
Published: Nov 4, 2025
Year: 2025
Period: Q3
Pharmaceuticals | Ghana
Neimeth International Pharmaceuticals PLC reported its financial results for the nine months ended 30 September 2025. Revenue increased 62 percent to N5.01 billion from N3.09 billion in the prior year period. Operating profit rose 120 percent to N1.66 billion. Finance costs grew 198 percent to N1.32 billion. Profit for the […]
Document type: Interim Reports
Published: Oct 30, 2025
Year: 2025
Period: Q3
Pharmaceuticals | Nigeria
May & Baker Nigeria Plc reports interim financial results for the nine-month period ended 30 September 2025. Key financial highlights: Revenue: ₦29.53 billion, compared to ₦21.82 billion in the prior year period. Profit for the period: ₦3.34 billion, compared to ₦1.89 billion in the prior year period. Basic Earnings Per […]
Document type: Interim Reports
Published: Oct 30, 2025
Year: 2025
Period: Q3
Pharmaceuticals | Nigeria
JULI PLC results for the nine months to 30 September 2025 show revenue at ₦383.11 million, a 10% increase year-on-year. The company recorded a net loss of (₦53.66 million) compared to a (₦3.78 million) loss in the prior period. Total assets were ₦166.70 million against total liabilities of ₦168.62 million, […]
Document type: Interim Reports
Published: Oct 30, 2025
Year: 2025
Period: Q3
Pharmaceuticals | Nigeria
Africure Pharmaceuticals Ltd reported its Q1 FY2025-2026 interim financial results for the three months ending 30 June 2025. Total assets decreased to USD 56.74 million from USD 58.44 million, with total equity down to USD 15.01 million. Group revenue was USD 5.71 million, down from USD 6.45 million, resulting in […]
Document type: Interim Reports
Published: Sep 29, 2025
Year: 2026
Period: Q1
Pharmaceuticals | Mauritius
Pharmaceutical leader in Ghana and West Africa, producing and distributing intravenous fluids and injectables with a focus on quality and compliance.
Pharmaceuticals | Ghana
Intravenous Infusions PLC reported total assets of GHS 41,923,511 as of 30 June 2025, a 12% decrease year-on-year. Total liabilities were GHS 26,039,366, an 11% decrease, while total equity decreased to GHS 15,884,145. Revenue for the period was GHS 7,073,903, down 44%, resulting in a gross profit of GHS 2,169,721 […]
Document type: Interim Reports
Published: Sep 9, 2025
Year: 2025
Period: HY
Pharmaceuticals | Ghana
THE INVESTOR MAILING LIST
The investor mailing list (IML) is an investor relations newsletter focused on African stock markets. The IML has all the essential share trading updates, financial documents, news and corporate announcements. The newsletter currently covers 11 African stock markets and is free.